Treatment of medication overuse headache - guideline of the EFNS headache panel

European Journal of Neurology

Volumn 18, Issue 9, 2011, Pages 1115-1121

  Evers, S ^a   Jensen, R ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Medication overuse headache; Withdrawal headache; Withdrawal therapy

Indexed keywords

AMITRIPTYLINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; OPIATE; PREDNISOLONE; PREDNISONE; TOPIRAMATE;

ARTICLE; DRUG ABUSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOTHERAPY; TRANSFORMED MIGRAINE; TREATMENT WITHDRAWAL; WITHDRAWAL SYNDROME;

ANALGESICS; HEADACHE DISORDERS, SECONDARY; HUMANS;

EID: 80051596013     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03497.x     Document Type: Article

References (57)

1. Headache Classification Subcommittee. The international classification of headache disorders. Cephalalgia 2004; 24(Suppl. 1): 1-160.
2. Headache Classification Committee. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalagia 1988; 8(Suppl. 7): 1-96.
3. Silberstein SD, Olesen J, Bousser MG, et al. International Headache Society The International Classification of Headache Disorders, 2nd Edition (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005; 25: 460-465.
4. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-746.
5. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. Eur J Neurol 2004; 11: 577-581.
6. Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn. Philadelphia: Lippincott, Williams & Wilkins, 2006.
7. Bauer B, Evers S, Lindörfer HW, Schuierer G, Henningsen H, Husstedt IW. Headache caused by a sphenoid mucocele but presenting as an ergotamine-induced headache. Headache 1997; 376: 460-462.
8. Baandrup L, Jensen R. Chronic post-traumatic headache - a clinical analysis in relation to the International Headache Classification 2nd Edition. Cephalalgia 2005; 25: 132-138.
9. Wolfe S, Van Stavern G. Characteristics of patients presenting with ocular pain. Can J Ophthalmol 2008; 43: 432-434.
10. Cady RK, Schreiber CP. Sinus problems as a cause of headache refractoriness and migraine chronification. Curr Pain Headache Rep 2009; 13: 319-325.
11. Willer L, Jensen R, Juhler M. Medication overuse as a cause of chronic headache in shunted hydrocephalus patients. JNNP 2010; 81: 1261-1264.
12. Evers S, Bauer B, Suhr S. Ergotamine-induced headache associated with cluster headache. Neurology 1996; 46: 291.
13. Paemeleire K, Bahra A, Evers S, Matharu M, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology 2006; 67: 109-113.
14. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo? Headache 1988; 28: 61-62.
15. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001; 41: 303-309.
16. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003; 43: 179-190.
17. Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004; 62: 1540-1544.
18. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 2010; 9: 391-401.
19. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62: 788-790.
20. Jensen R, Zeeberg P, Dehlendorff C, Olesen J. Predictors of outcome of the treatment programme in a multidisciplinary headache centre. Cephalalgia 2010; 30: 1214-1224.
21. Ravishankar K. Medication overuse headache in India. Cephalalgia 2008; 28: 1223-1226.
22. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48: 1157-1168.
23. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006; 26: 1192-1198.
24. Rossi P, Jensen R, Nappi G, Allena M; the COMOESTAS Consortium. A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 2009; 10: 407-417.
25. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57: 1694-1698.
26. Bøe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: predictors of outcome 1year after withdrawal therapy. Eur J Neurol 2009; 16: 705-712.
27. Altieri M, Di Giambattista R, Di Clemente L, et al. Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: a pilot study. Cephalalgia 2009; 29: 293-299.
28. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006; 26: 1097-1105.
29. Grazzi L, Andrasik F, Usai S, Bussone G. In-patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: results at one-year follow-up. Neurol Sci 2008; 29(Suppl. 1): 161-163.
30. Paemelaire K, Crevitis L, Goadsby PH, Kaube H. Practical management of medication overuse headache. Acta Neurol Belg 2006; 106: 43-51.
31. Obermann M, Katsarava Z. Management of medication overuse headache. Expert Rev Neurother 2007; 7: 1145-1155.
32. Straube A, May A, Kropp P, et al. Therapie primärer chronischer Kopfschmerzen: Chronische Migräne, chronischer Kopfschmerz vom Spannungstyp und andere chronische tägliche Kopfschmerzen. Nervenheilkunde 2007; 26: 186-199.
33. Hagen K, Albretsen C, Vilming ST, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 2009; 29: 221-232.
34. Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol 2011; 18: 396-401.
35. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007; 27: 814-823.
36. Silberstein SD, Lipton RB, Dodick DW, et al. Topiramate Chronic Migraine Study Group Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007; 47: 170-180.
37. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006; 66: 1894-1898.
38. Dodick DW, Turkel CC, DeGryse RE, et al. Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010; 50: 921-936.
39. Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 2009; 29: 1021-1027.
40. Bonuccelli U, Nuti A, Lucetti C, Pavese N, Dell'Agnello G, Muratorio A. Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia 1996; 16: 198-200.
41. Trucco M, Meineri P, Ruiz L, Gionco M; Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee (Neurological Hospital Interregional Group for the Study of Headaches). Medication overuse headache: withdrawal and prophylactic therapeutic regimen. Headache 2010; 50: 989-997.
42. Bøe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007; 69: 26-31.
43. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000; 20: 107-113.
44. Pageler L, Katsarava Z, Diener HC, Limmroth V. Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 2008; 28: 152-156.
45. Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1991; 31: 205-209.
46. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337: 1442-1443.
47. Ghiotto N, Sances G, Galli F, et al. Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia 2009; 29: 233-243.
48. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005; 25: 12-15.
49. Grande RB, Aaseth K, Benth JŠ, Lundqvist C, Russell MB. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol 2011; 18: 129-137.
50. Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia 2008; 28: 1196-1200.
51. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999; 19: 44-49.
52. Sances G, Ghiotto N, Galli F, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia 2010; 30: 329-336.
53. Bøe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia 2009; 29: 855-863.
54. Wang SJ, Fuh JL, Lu SR, Juang KD. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006; 66: 193-197.
55. Dyb G, Holmen TL, Zwart JA. Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 2006; 66: 198-201.
56. Hershey AD. Chronic daily headache in children. Expert Opin Pharmacother 2003; 4: 485-491.
57. Kossoff EH, Mankad DN. Medication-overuse headache in children: is initial preventive therapy necessary? J Child Neurol 2006; 21: 45-48.